4.8 Article

Inhibition of epithelial cell migration and Src/FAK signaling by SIRT3

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1800440115

关键词

mitochondria; SIRT3; cancer; metabolism; cell migration

资金

  1. American Heart Association [15POST25560077]
  2. National Institutes of Health from the National Institute of Diabetes and Digestive and Kidney Diseases [R01DK103295]
  3. National Cancer Institute [R01CA213062]
  4. Ludwig Center at Harvard
  5. Glenn Foundation for Medical Research
  6. NATIONAL CANCER INSTITUTE [R01CA213062, R01CA166284] Funding Source: NIH RePORTER
  7. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103295] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Metastasis remains the leading cause of cancer mortality, and reactive oxygen species (ROS) signaling promotes the metastatic cascade. However, the molecular pathways that control ROS signaling relevant to metastasis are little studied. Here, we identify SIRT3, a mitochondrial deacetylase, as a regulator of cell migration via its control of ROS signaling. We find that, although mitochondria are present at the leading edge of migrating cells, SIRT3 expression is down-regulated during migration, resulting in elevated ROS levels. This SIRT3-mediated control of ROS represses Src oxidation and attenuates focal adhesion kinase (FAK) activation. SIRT3 overexpression inhibits migration and metastasis in breast cancer cells. Finally, in human breast cancers, SIRT3 expression is inversely correlated with metastatic outcome and Src/FAK signaling. Our results reveal a role for SIRT3 in cell migration, with important implications for breast cancer progression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据